Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea Holdings Inc. due to allegations of misleading statements and financial misrepresentations that have led to significant investor losses [2][4]. Group 1: Legal Investigation and Claims - Investors who suffered losses exceeding $50,000 in Fortrea between July 3, 2023, and February 28, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - A federal securities class action has been filed against Fortrea, with an August 1, 2025, deadline for investors to seek the role of lead plaintiff [2]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea overestimated revenue contributions from Pre-Spin Projects and overstated cost savings from exiting Transition Services Agreements (TSAs), leading to inflated EBITDA targets for 2025 [4]. - The company's public statements regarding its business model and financial prospects were deemed materially false and misleading [4]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in its business model and a stock price drop of $2.73 per share (12.29%) [5]. - Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, after the company canceled two scheduled conferences, resulting in a stock price decline of $1.90 per share (8.06%) [6]. - Following the announcement of disappointing financial results on March 3, 2025, Fortrea's stock price fell by $3.47 per share (25.05%) [7].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Petco Health and Wellness Company, Inc. due to allegations of misleading statements and failure to disclose critical business issues, with a deadline for investors to seek lead plaintiff status in a federal securities class action by August 29, 2025 [2][4]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who suffered losses exceeding $100,000 in Petco between January 14, 2021, and June 5, 2025, to discuss their legal rights [1]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. - The complaint alleges that Petco's pandemic-related business advantages were unsustainable and that the company overstated its product strategy and growth potential [4]. Group 2: Financial Performance - On June 5, 2025, Petco reported net sales of $1.5 billion for the first quarter of 2025, reflecting a 2.3% year-over-year decline [5]. - Following the financial results announcement, Petco's stock price dropped by $0.85 per share, or 23.34%, closing at $2.78 per share on June 6, 2025 [5]. Group 3: Class Action Details - The lead plaintiff in a class action is the investor with the largest financial interest who directs the litigation on behalf of the class [6]. - Any member of the putative class can move the court to serve as lead plaintiff or remain an absent class member without affecting their ability to share in any recovery [6]. Group 4: Additional Information - The firm is also seeking information from whistleblowers, former employees, and shareholders regarding Petco's conduct [7]. - For more details on the class action, interested parties can visit the firm's website or contact the partner directly [7].

Group 1 - Halper Sadeh LLC is investigating Core Scientific's sale to CoreWeave, where shareholders will receive 0.1235 newly issued shares of CoreWeave Class A common stock for each share of Core Scientific common stock, resulting in Core Scientific shareholders owning less than 10% of the combined company after the transaction [1] - WNS (Holdings) Limited is being sold to Capgemini for $76.50 per share, prompting an investigation into potential shareholder rights and options [2] - The firm may seek increased consideration for shareholders, additional disclosures, or other relief and benefits on behalf of shareholders, operating on a contingent fee basis [3] Group 2 - Shareholders are encouraged to contact Halper Sadeh LLC for a free discussion regarding their legal rights and options, with contact details provided for further inquiries [4]

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Sarepta Therapeutics, Inc. due to significant losses suffered by investors related to the company's product ELEVIDYS, with a deadline for lead plaintiff applications set for August 25, 2025 [2][4]. Group 1: Legal Investigation and Claims - The law firm is encouraging investors who experienced losses exceeding $100,000 in Sarepta between June 22, 2023, and June 24, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Sarepta, alleging violations of federal securities laws, including making false or misleading statements regarding the safety and efficacy of ELEVIDYS [4][9]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [3]. Group 2: Product Safety Issues - The complaint alleges that ELEVIDYS posed significant safety risks, including severe side effects that were not adequately detected during clinical trials [4]. - Following a safety update on March 18, 2025, Sarepta's stock price fell by $27.81 per share, or 27.44%, after a patient died post-treatment with ELEVIDYS [5]. - On April 4, 2025, Sarepta disclosed that regulatory authorities requested a review of the death, leading to a further stock price decline of $4.18 per share, or 7.13% [6]. - A second patient death due to acute liver failure was reported on June 15, 2025, resulting in a significant stock price drop of $15.24 per share, or 42.12% [7][8]. - The FDA issued a Safety Communication on June 24, 2025, regarding the investigation into the risk of acute liver failure associated with ELEVIDYS, causing an additional stock price decline of $1.52 per share, or 8.01% [8][9].

Core Viewpoint - Fortrea Holdings Inc. is facing a class action securities lawsuit due to alleged securities fraud that occurred between July 3, 2023, and February 28, 2025, impacting investors adversely [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Fortrea Holdings Inc. overestimated revenue contributions from its long-term projects, known as the Pre-Spin Projects, for the year 2025 [2]. - It is alleged that the company overstated potential cost savings from exiting transition services agreements, leading to inflated EBITDA targets for 2025 [2]. - The viability of Fortrea's post-spin-off business model and its financial prospects were reportedly overstated, resulting in materially false and misleading public statements [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until August 1, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this role [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees, with no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Organon & Co. for alleged securities fraud affecting investors between October 31, 2024, and April 30, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Organon's management made overly positive statements while concealing material adverse facts about the company's capital allocation priorities, particularly regarding a significant debt reduction strategy following the acquisition of Dermavant [2]. - As a result of these actions, Organon reduced its regular quarterly dividend by 70%, leading to a dramatic decline in stock price from $12.93 per share on April 30, 2025, to $9.45 per share on May 1, 2025, representing a drop of over 27% in just one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until July 22, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require serving in this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securities litigation, having secured hundreds of millions of dollars for shareholders over the past 20 years and consistently ranking among the top securities litigation firms in the United States [4].

Core Viewpoint - A class action securities lawsuit has been filed against Petco Health and Wellness Company, Inc. for alleged securities fraud affecting investors between January 14, 2021, and June 5, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Petco's pandemic-related business advantages were not sustainable and that its business model, which focuses on premium pet food, was overstated [2]. - It is alleged that the defendants minimized the true extent of the issues facing Petco, including the necessary changes to address these issues and the potential negative impacts on comparable sales [2]. - The lawsuit asserts that the defendants misrepresented Petco's ability to achieve sustainable and profitable growth, leading to materially false and misleading public statements [2]. Group 2: Next Steps for Investors - Investors who experienced losses in Petco during the specified timeframe have until August 29, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be eligible for compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

NEW YORK, July 8, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in 3D Systems Corporation ("3D Systems Corporation" or the "Company") (NYSE: DDD) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of 3D Systems Corporation investors who were adversely affected by alleged securities fraud between August 13, 2024 and May 12, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra-1/3d-s ...

Core Viewpoint - A class action securities lawsuit has been filed against PepGen Inc. due to alleged securities fraud affecting investors between March 7, 2024, and March 3, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that PepGen's lead product candidate, PGN-EDO51, was misrepresented as being more effective and safe than it actually is [2]. - Allegations include that the phase two CONNECT2 study was dangerous or deficient for FDA approval, leading to the likelihood of halting the study [2]. - The complaint asserts that the public statements made by the defendants were materially false and misleading throughout the relevant period [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 8, 2025, to request appointment as lead plaintiff, although participation in any recovery does not require this [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the U.S. [4].

Core Viewpoint - A class action securities lawsuit has been filed against Reddit, Inc. alleging securities fraud that negatively impacted investors between October 29, 2024, and May 20, 2025 [1] Group 1: Lawsuit Details - The complaint claims that the defendants made false statements regarding the impact of changes in Google Search's algorithm, which led to a significant reduction in traffic to Reddit [2] - It is alleged that the defendants were aware that users were finding answers directly on Google Search, rather than visiting Reddit, which contributed to the decline in user engagement [2] - The lawsuit asserts that the defendants lacked a reasonable basis for their forecasts on user rates and advertising revenues, resulting in materially false and misleading public statements [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until August 18, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require this [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees, and there is no obligation to participate [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4] - The firm has over 70 employees dedicated to serving clients in complex securities litigation and has been ranked in ISS Securities Class Action Services' Top 50 Report for seven consecutive years [4]